Who is sponsoring NCT03877315?

NCT03877315 is sponsored by Zealand University Hospital.

What drugs are being tested in NCT03877315?

Interventions in NCT03877315: Stemmed shoulder arthroplasty, Biomet Comprehensive® Total Shoulder System., Stemless shoulder arthroplasty, Biomet Comprehensive® Nano Shoulder System..

What condition does NCT03877315 study?

NCT03877315 studies Shoulder Pain, Shoulder Osteoarthritis, Shoulder Arthritis.

Is NCT03877315 still recruiting?

NCT03877315 is currently status unknown. Last updated 22 December 2022.

Last reviewed 2022-12-22 · How we verify

NCT03877315

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Patient Reported Outcome After Stemmed Versus Stemless Total Shoulder Arthroplasty for Glenohumeral Osteoarthritis.

Status unknown NA Last updated 22 December 2022

What this trial tests

NA trial testing Stemmed shoulder arthroplasty, Biomet Comprehensive® Total Shoulder System. in Shoulder Pain in 78 participants. Status unknown.

Timeline

1 August 2019

Primary endpoint
28 February 2022

1 August 2023

Quick facts

Lead sponsor	Zealand University Hospital
Phase	NA
Status	Status unknown
Study type	INTERVENTIONAL
Allocation	randomized
Design	parallel
Masking	single
Primary purpose	treatment
Enrollment	78
Start date	1 August 2019
Primary completion	28 February 2022
Estimated completion	1 August 2023
Sites	1 location across Denmark

Drugs / interventions tested

Stemmed shoulder arthroplasty, Biomet Comprehensive® Total Shoulder System.
Stemless shoulder arthroplasty, Biomet Comprehensive® Nano Shoulder System.

Conditions studied

Shoulder Pain — all drugs for Shoulder Pain →
Shoulder Osteoarthritis — all drugs for Shoulder Osteoarthritis →
Shoulder Arthritis — all drugs for Shoulder Arthritis →

Sponsor

Zealand University Hospital

Who can join

18 and older, any sex, with Shoulder Pain or Shoulder Osteoarthritis. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Stemless shoulder arthroplasty systems with uncemented metaphyseal fixation have been used in Europe for glenohumeral osteoarthritis since 2004. The stemless design has several theoretical advantages compared with the stemmed shoulder arthroplasty systems: restoring patients' anatomy, preserving humeral bone stock, and few complications in component removal if the need for a revision arthroplasty arises. The purpose of the study is to compare the short-term, patient-reported outcome of stemless and stemmed total shoulder arthroplasty.

Publications & conference data

1 peer-reviewed publication reference this trial (live from Europe PMC):

Patient-reported outcome after stemmed versus stemless total shoulder arthroplasty for glenohumeral osteoarthritis: a patient-blinded randomized clinical trial.
Issa Z, Rasmussen JV, Petersen JK, Schantz K, et al · · 2019 · cited 7× · PMID 31300025 · DOI 10.1186/s13063-019-3535-9

Verify or expand the search:

Other recruiting trials for Shoulder Pain

Currently open trials in the same condition.

NCT07493226 — Efficacy of Chemically Distinct Nonsteroidal Anti-Inflammatory Drugs (NSAIDs) and Pain Phenotypes in Adhesive Capsulitis · NA · recruiting
NCT07493213 — USG-Guided Shoulder Injections in Frozen Shoulder · NA · recruiting
NCT07424638 — Interscalene Block Versus Anterior Suprascapular Block for Post-Thoracotomy Shoulder Pain · NA · recruiting
NCT07394673 — Ultrasound-Guided Serratus Posterior Superior Intercostal Plane Block for Analgesia in Arthroscopic Shoulder Surgery · NA · recruiting
NCT07334171 — Inspiratory Muscle Strength and Diaphragm Thickness in People With Shoulder Pain in Tennis Players · active not recruiting

Other Zealand University Hospital trials

Trials by the same sponsor.

NCT07373561 — Post-Intensive Care Syndrome and Associated Symptom Burden Among Danish ICU Survivors · not yet recruiting
NCT07386080 — Carbergoline for Antipsychotic Induced Hyperprolactinemia. · Phase 4 · not yet recruiting
NCT07482150 — The Connect Trial: Connecting Hospital Patients to Alcohol Care · NA · not yet recruiting
NCT07460999 — Singing Training vs Usual Care 6-18 Months After Surgical Resection for Non-small Cell Lung Cancer (NSCLC) · NA · recruiting
NCT07365527 — Sonoporation and Tumor Microenvironment Response in Colorectal Liver Metastases · NA · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03877315 (US National Library of Medicine, public domain)
Publications: Europe PMC API search by NCT ID, retrieved 10 June 2026
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Zealand University Hospital
Last refreshed: 22 December 2022

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03877315.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing